Stock Screener - US Stocks, Forex and ETFs Please enable JavaScript to view this page content properly  
     
   MACD(12,26,9) Crossed Above Zero     
Criteria:
MACD(12,26,9) Crossed Above Zero
  Back to MACD Stock Screener
           
   Symbol   Name   Industry   Sector   Exchange  Cap, mln  Last  Change  Change, %  Volume
 ABT    Abbott Laboratories  Medical Appliances & Equipment Healthcare NYSE 95,230  55.70  0.78 1.4 9,860,000
 ACTG    Acacia Res-Acacia  Business Services Services NASDAQ 215  4.30  0.05 1.2 168,891
 AGND    Wisdomtree Neg Duration US Agg Bond Fund  Exchange Traded Fund Financial NASDAQ   43.52  0.10 0.2 274
 AGU    Agrium Inc  Agricultural Chemicals Basic Materials NYSE 15,050  110.93  3.68 3.4 540,506
 AHL    Aspen Insurance Holdings  Property & Casualty Insurance Financial NYSE 2,440  41.75  0.62 1.5 829,583
 AHP    Ashford Hospitality Prime Inc  REIT - Hotel/Motel Financial NYSE 295  9.85  0.06 0.6 342,424
 AMLP    Alps Alerian MLP ETF  Exchange Traded Fund Financial NYSE   10.73  0.05 0.5 4,570,000
 ANDX    Andeavor Logistics LP    NYSE 10,040  47.06  1.04 2.3 616,674
 ANGO    Angiodynamics Inc  Medical Instruments & Supplies Healthcare NASDAQ 633  17.14  0.10 0.6 147,534
 AOBC    American Outdoor Brands Corp  Diversified Machinery Industrial Goods NASDAQ 734  14.10  0.69 5.0 2,810,000
Please sign up for viewing the full list of stocks


Education MACD - Technical Analysis from A to Z
The MACD (Moving Average Convergence/Divergence) is a trend following momentum indicator that shows the relationship between two moving averages of prices. The MACD is the difference between a 26-day and 12-day exponential moving average. A 9-day exponential moving average, called the "signal" line is plotted on top of the MACD to show buy/sell opportunities. The MACD proves most effective in wide-swinging trading markets. There are three popular ways to use the MACD: crossovers, overbought/oversold conditions, and divergences. Learn more




Disclaimer - FAQ - Contact Us
Copyright ©2008-2017 Market In&Out. All rights reserved.
Best viewed in